(Q40511597)

English

Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival

scientific article published on May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Carlson K

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

985-990

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Treatment of Renal Failure Associated With Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

21 January 2018

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

21 January 2018

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

21 January 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal failure in multiple myeloma. Pathogenesis and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive treatment of renal failure in patients with myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704948

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704948

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40511597&oldid=2203748223"